Vivo Capital’s Agile Therapeutics AGRX Stock Holding History

Vivo Capital’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-757	Closed	-$2.21M	–	38
2019 Q2	$2.21M	Hold	757	–	–	0.21%	41
2019 Q1	$2.29M	Hold	757	–	–	0.23%	41
2018 Q4	$872K	Hold	757	–	–	0.11%	40
2018 Q3	$555K	Hold	757	–	–	0.06%	41
2018 Q2	$742K	Hold	757	–	–	0.1%	37
2018 Q1	$3.89M	Hold	757	–	–	0.55%	27
2017 Q4	$4.07M	Hold	757	–	–	0.87%	23
2017 Q3	$6.75M	Hold	757	–	–	1.36%	18
2017 Q2	$5.68M	Hold	757	–	–	1.43%	15
2017 Q1	$4.85M	Hold	757	–	–	1.43%	13
2016 Q4	$8.63M	Sell	757 -253	-25%	-$3.55M	2.84%	11
2016 Q3	$14.1M	Hold	1,010	–	–	4.39%	7
2016 Q2	$15.4M	Hold	1,010	–	–	4.2%	7
2016 Q1	$12.5M	Buy	+1,010	New	+$13M	3.15%	10

Other funds holding AGRX

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return